This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Medimmune Limited. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2023
Title: Richard Williams: Innovator in Antibody Research
Introduction
Richard Williams is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 2 patents, his work focuses on innovative solutions for medical applications.
Latest Patents
His latest patents include "Nucleic acids encoding anti-PAR2 antibodies and uses thereof." This patent provides antibodies and antigen-binding fragments capable of binding to PAR2. In some embodiments, the anti-PAR2 antibodies or antigen-binding fragments bind PAR2 in a pH-dependent manner. The disclosure further provides methods for making and using these antibodies and antigen-binding fragments. Another significant patent is "Anti-PAR2 antibodies and uses thereof," which shares similar features and applications as the previous one.
Career Highlights
Richard Williams is currently associated with Medimmune Limited, where he continues to advance his research in antibody development. His work has the potential to impact therapeutic strategies significantly.
Collaborations
Some of his notable coworkers include Claire Louise Dobson and Ian Gurrell, who contribute to the innovative environment at Medimmune Limited.
Conclusion
Richard Williams exemplifies the spirit of innovation in the biotechnology sector, with his patents paving the way for future advancements in antibody research. His contributions are vital for the ongoing development of medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile